Evalve

Evalve, Inc., founded in 1999, specializes in the design, development, manufacture, and marketing of devices for percutaneous cardiac valve repair. The company's flagship product, the MitraClip® system, focuses on mitral valve repair and aims to minimize the risks, trauma, and costs associated with traditional open-heart surgery. Evalve's MitraClip® system received CE mark approval in 2008, marking it as the world's first percutaneous valve repair system. In October 2009, Evalve was acquired by Abbott Vascular, Inc., expanding its reach and resources. Evalve primarily serves the medical and healthcare markets, targeting hospitals and cardiac care centers. The business model revolves around the sale and distribution of its specialized medical devices, generating revenue through product sales and clinical support services.

Keywords: cardiac, valve repair, MitraClip, percutaneous, mitral valve, CE mark, Abbott Vascular, medical devices, healthcare, hospitals.